1127 Connecticut Ave NW
Washington, DC 20036
Recently, UN officials have begun using a human rights agenda to govern the activities of corporations throughout the world. The latest UN effort involves the promotion of an ambiguous “right to health” and its related access to medicines. The UN effort to globally govern pharmaceutical companies is being led by Paul Hunt, the UN Special Rapporteur on the “right of everyone to the enjoyment of the highest attainable standard of physical and mental health.” On September 19, 2007, Mr. Hunt published draft Human Rights Guidelines for Pharmaceutical Companies in relation to Access to Medicines. The Draft Guidelines set forth a human rights regimen designed to pressure pharmaceutical companies to embrace a “right to health” the scope of which has never been established in international law. The Draft Guidelines call for:
Panelists include: